Vasomune Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vasomune Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vasomune Inc Today - Breaking & Trending Today

AnGes : Tie2 receptor agonist (AV 001), co development product, received fast track designation from the U.S. FDA

Published: May 29, 2024

May 29, 2024 Company Name: AnGes Inc. Presentative: Ei Yamada, President & CEO Tie2 receptor agonist ,co-development...

Source: marketscreener.com

Related Topics:

United StatesBrian JahnsDrug AdministrationAnges IncCompany NameSunnybrook Research Institute At HospitalVasomune Therapeutics IncVasomune IncNational Research Council CanadaVasomune TherapeuticsFast TrackTherapeutics IncTrack DesignationChief OperatingUnited States DepartmentSunnybrook Research InstituteSunnybrook HospitalHepatocyte Growth Factor